(PharmaNewsWire.Com, August 31, 2021 ) The Women’s Health Market size was estimated at $32.4 billion in 2020, projected to grow at a CAGR of 4.2% during the forecast period 2021-2026. Women's health is the field of medicine concerned with the prevention and diagnosis of diseases and disorders affecting a woman's physical and emotional well-being. Women's health encompasses a broad variety of specialties and focus areas, including Postmenopausal Osteoporosis, Infertility, Endometriosis, Contraceptives, Menopause, and PCOS among others. Additionally, Changes in eating patterns, stress are also important contributors to hormonal imbalance in women.
Women are likely to have fertility problems as a result of this. The most common causes of infertility are ovulation complications, endometriosis, and PCOS. Moreover women's well-being is a priority for governments and private organizations all over the world. One of the main factors expected to drive the demand in developing countries is women's coverage plans. Various insurance schemes in the United States and Australia, for example, provide preventive care for women without charging a copayment. However, the high costs associated with clinical services and stringent regulations along with certain side-effects associate with the medicine is predicted to pose a threat to the market's growth during the forecast period 2021-2026.
Women’s Health Market Segment Analysis- By Application
On the basis of application, the market is divided into Postmenopausal Osteoporosis, Infertility, Endometriosis, Contraceptives, Menopause, POS and Others applications. Contraceptives segment account for the highest market share in 2020 owing to the rising prevalence of unintended pregnancies, and large number of birth-control pill product launches by key players. For instance According to a study conducted by The Guttmacher Institute, there were approximately 121 million unwanted pregnancies between 2015 and 2019. Corresponding to a global average of 64 women per 1,000, aged 15 to 49.
However as a result of the high fertility-related conditions in developing countries, the hormonal infertility segment is expected to expand rapidly owing to which the segment is projected to grow at a faster CAGR of 5.8% during the forecast period 2021-2026. Hormonal imbalances, such as prolactin, estrogen, and thyroid imbalances, are becoming more common in women as a result of factors such as stress, fueling demand for medication to improve health.
Women’s Health Market Segment Analysis - By Distribution Channel
Based on Distribution Channel, the global Women’s Health Market is segmented into Online Pharmacies, Hospital Pharmacies, Retail Pharmacies and other channels. The hospital pharmacy segment accounted for the majority of the market share. The segment's dominance can be explained by the fact that most prescriptions for different treatments can only be administered after rigorous evaluations by qualified medical professionals at these facilities. Furthermore, government policies aimed at enhancing healthcare services and infrastructure have helped hospital pharmacies gain popularity among the general public thereby contributing to growth of the segment.
Online Pharmacies segment account for the highest market share in 2020 and is projected to grow at a CAGR of 5.9% during the forecast period 2021-2026. The dominance is due to evolving consumers and increasing demand from tier I and II cities where ecommerce penetration is increasing rapidly. Moreover, along with multiple options the customers can compare for the best price & features, from the comfort of their home or as per an individual’s preference which is further poised to increase the online Pharmacies segment.
Women’s Health Market Segment Analysis - By Geography
Based on geography, North America dominated the Women’s Health Market with a region share of 40.7% in 2020 followed by Europe and APAC. Rising adoption of the women’s health products and supportive government programs and policies are the major factors propelling the growth in this region. Furthermore, the presence of a large number of pharmaceutical companies that invest heavily in research, as well as easy access to technologically advanced instruments, is expected to propel market growth in this area.
However, Asia Pacific region is predicted to see the demand maturing in Women’s Health Market owing to the rising spending in emerging economies such as China and India, as well as increased concern about women's health. Furthermore, policymakers in developing countries are taking steps to raise awareness about Postmenopausal Osteoporosis, Infertility, Endometriosis diseases along with their diagnosis and treatment options which is further predicted to drive the market during the forecast period 2021-2026.
Frequent outbreaks of diseases, such as anemia, osteoporosis, ductal cancer, and menopause, have sparked a surge in demand for products to treat these illnesses affecting women. Growing public understanding of these diseases, their adverse consequences, and potential early detection and treatment approaches to avoid future outbreaks are expected to drive global market development. Furthermore, the easy availability of several medicines to treat hormonal imbalances along with the increasing investments by key market player and government organizations around the world, is set to propel the market forward during the forecast period 2021-2026.
Women’s Health Market Challenge
High Cost of the Product
Despite the increased diseases and supportive government programs and policy’s, some factors are preventing product acceptance. The high costs associated with clinical services along with certain side-effects associate with the medicines is currently limiting the adoption of the products. Moreover the rising stringency in the government regulation also poses a major threat thereby, acting as major impediment for market's growth.
Women’s Health Market Landscape:
Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Women’s Health Market. Key companies of this market are Allergan, Bayer AG, Merck & Co., Inc., Pfizer, Teva Pharmaceuticals, Agile Therapeutics, Amgen, Inc., AstraZeneca, Bristol-Myers Squibb and Ferring B.V.
Developments:
In June 2019, AbbVie Inc. announced that it had reached an agreement with ALLERGAN to purchase the assets available with ALLERGAN for approximately USD 63 billion. This acquisition is a strategic move for the companies because their combined expertise would open up a wide range of applications thereby driving innovation in the Women’s Health Market.
In May 2019, Agile Therapeutics resubmitted its Twirla new drug application in response to a Complete Response Letter from the FDA in December 2017, which found flaws in the product's manufacturing process quality control
Key Takeaways
Geographically, The North America region held 40.7% of the total market share in 2020 owing to the rising adoption of the women’s health products and supportive government programs and policy’s.
Increase in the population of women over 60, an increase in the adoption of unhealthy lifestyle habits, and the launch of novel medicines for women are the major driving force for Women’s Health Market during forecast period 2021-2026.
Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Women’s Health Market.
For more Lifesciences and Healthcare Market reports, Please click here
About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
